Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free SUPN Stock Alerts

Supernus Pharmaceuticals (SUPN) Short Interest Ratio & Short Volume

Supernus Pharmaceuticals logo
$44.41 0.00 (0.00%)
As of 06/12/2026 04:00 PM Eastern
Compare

Supernus Pharmaceuticals Short Interest Overview

As of May 29, 2026, Supernus Pharmaceuticals (SUPN) had a short interest of 5.42 million shares sold short, representing 10.24% of the public float. This marks a 14.53% increase in short interest since the prior report. The short interest ratio (days to cover) is 9.5, meaning it would take 9.5 days of the average trading volume of 550,251 shares to cover all short positions.

Current Short Interest
5,418,515 shares
Previous Short Interest
4,731,258 shares
Change Vs. Previous Month
14.53%
Dollar Volume Sold Short
$250.23 million
Short Interest Ratio
9.5 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
58,040,000 shares
Short Percent of Float
10.24%
Today's Trading Volume
825,357 shares
Average Trading Volume
550,251 shares
Today's Volume Vs. Average
150%
Short Selling Supernus Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SUPN Short Interest Over Time

SUPN Days to Cover Over Time

SUPN Percentage of Float Shorted Over Time

Supernus Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20265,418,515 shares $250.23 million +14.5%10.2%9.5 $46.18
5/15/20264,731,258 shares $233.87 million +0.2%8.9%5.29 $49.43
4/30/20264,721,234 shares $226.62 million -0.2%8.9%8.54 $48.00
4/15/20264,732,523 shares $236.34 million +4.4%9.0%9.31 $49.94
3/31/20264,532,867 shares $234.30 million +8.2%8.6%7.52 $51.69
3/13/20264,188,850 shares $209.07 million +2.6%8.0%6.51 $49.91
2/27/20264,081,384 shares $223.37 million +1.5%7.8%4.24 $54.73
2/13/20264,021,038 shares $204.43 million +0.8%7.7%5.7 $50.84
1/30/20263,990,080 shares $192.16 million -3.2%7.6%5.6 $48.16
1/15/20264,122,399 shares $207.19 million -6.0%7.9%6.55 $50.26
12/31/20254,384,311 shares $217.90 million -8.9%8.4%6.99 $49.70
12/15/20254,812,734 shares $227.55 million -3.6%9.2%8.14 $47.28
11/28/20254,994,703 shares $228.03 million -4.0%9.6%6.8 $45.66
11/14/20255,202,679 shares $234.12 million +6.8%10.2%3.68 $45.00
10/31/20254,870,017 shares $268.48 million -1.7%9.5%6.25 $55.13
10/15/20254,950,000 shares $243.89 million -4.6%9.4%6.1 $49.27
9/30/20255,190,000 shares $248.03 million +3.4%9.8%6.3 $47.79
9/15/20255,020,000 shares $220.83 million +4.6%9.5%6.1 $43.99
8/31/20254,800,000 shares $216.58 million +2.1%9.1%5.8 $45.12
8/15/20254,700,000 shares $200.64 million -7.5%8.9%5.9 $42.69
7/31/20255,080,000 shares $178.31 million -0.4%9.9%7 $35.10
7/15/20255,100,000 shares $170.90 million +4.1%N/A8.8 $33.51
6/30/20254,900,000 shares $154.45 million +21.6%9.3%8.7 $31.52
6/15/20254,030,000 shares $129.08 million -4.7%7.6%7.6 $32.03
5/31/20254,230,000 shares $134.47 million +1.2%8.0%8 $31.79
5/15/20254,180,000 shares $135.77 million +5.3%7.9%7.1 $32.48
4/30/20253,970,000 shares $128.95 million -4.1%N/A6.4 $32.48
4/15/20254,140,000 shares $130.24 million -11.2%8.3%6.8 $31.46
3/31/20254,660,000 shares $152.62 million -7.4%9.3%7.8 $32.75
3/15/20255,030,000 shares $157.24 million -17.0%10.0%9 $31.26
2/28/20256,060,000 shares $194.28 million +5.9%12.1%12.4 $32.06
2/15/20255,720,000 shares $223.71 million -0.4%10.8%13.6 $39.11
1/31/20255,740,000 shares $220.24 million -4.7%10.9%15.9 $38.37
1/15/20256,020,000 shares $230.63 million -2.9%11.4%16.6 $38.31
12/31/20246,200,000 shares $224.19 million -6.6%11.7%17.2 $36.16
12/15/20246,640,000 shares $240.17 million +3.0%12.6%19.4 $36.17
11/30/20246,450,000 shares $235.88 million -1.1%12.2%17.8 $36.57
11/15/20246,520,000 shares $231.92 million -4.1%12.3%18.3 $35.57
10/31/20246,800,000 shares $231.68 million +0.4%12.9%18.1 $34.07
10/15/20246,770,000 shares $226.93 million -2.9%12.8%17.2 $33.52
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
9/30/20246,970,000 shares $217.32 million +2.5%13.2%15.8 $31.18
9/15/20246,800,000 shares $211.55 million +2.0%12.9%14.1 $31.11
8/31/20246,670,000 shares $234.52 million +1.7%12.6%12.5 $35.16
8/15/20246,560,000 shares $224.68 million +6.5%12.4%11.4 $34.25
7/31/20246,160,000 shares $183.69 million -2.4%11.7%9.8 $29.82
7/15/20246,310,000 shares $181.29 million +3.1%12.0%10.9 $28.73
6/30/20246,120,000 shares $163.71 million +4.9%11.6%11 $26.75
6/15/20245,834,000 shares $151.63 million +11.8%11.1%11 $25.99
5/31/20245,220,000 shares $141.57 million +6.3%9.9%10.6 $27.12
5/15/20244,910,000 shares $141.11 million +1.9%9.3%10.2 $28.74
4/30/20244,820,000 shares $145.08 million +3.0%9.2%11.8 $30.10
4/15/20244,680,000 shares $140.35 million -2.9%8.9%12.1 $29.99
3/31/20244,820,000 shares $164.41 million -2.0%9.2%12.3 $34.11
3/15/20244,920,000 shares $162.26 million +11.6%9.4%13 $32.98
2/29/20244,410,000 shares $130.98 million +9.4%8.4%12.2 $29.70
2/15/20244,030,000 shares $115.50 million +7.8%7.7%12.1 $28.66
1/31/20243,740,000 shares $103.52 million -16.9%7.1%10.6 $27.68
1/15/20244,500,000 shares $127.08 million +0.2%8.6%11.8 $28.24
12/31/20234,490,000 shares $129.94 million +0.9%N/A0 $28.94
12/15/20234,450,000 shares $121.26 million +7.0%8.5%10.9 $27.25
11/30/20234,160,000 shares $113.36 million +0.2%7.9%9.5 $27.25
11/15/20234,150,000 shares $118.65 million +4.5%7.9%9.3 $28.59
10/31/20233,970,000 shares $94.68 million +1.8%7.6%8.6 $23.85
10/15/20233,900,000 shares $96.88 million -0.5%7.5%8.6 $24.84
9/30/20233,920,000 shares $108.07 million -9.1%7.5%9.1 $27.57
9/15/20234,310,000 shares $125.98 million +3.9%8.2%9.6 $29.23
8/31/20234,150,000 shares $132.14 million +1.0%7.9%8.9 $31.84
8/15/20234,110,000 shares $130.86 million -1.0%7.9%8.8 $31.84
7/31/20234,150,000 shares $127.36 million -25.0%8.0%8.7 $30.69
7/15/20235,530,000 shares $166.07 million -0.9%10.6%12.5 $30.03
6/30/20235,580,000 shares $167.73 million +2.2%10.7%12.4 $30.06
6/15/20235,460,000 shares $183.40 million +3.2%10.5%12.5 $33.59
5/31/20235,290,000 shares $175.31 million +10.9%10.1%13.3 $33.14
5/15/20234,770,000 shares $165.71 million +6.5%9.1%11.6 $34.74
4/30/20234,480,000 shares $165.13 million +10.6%8.6%11.2 $36.86
4/15/20234,050,000 shares $146.04 million +1.5%7.8%9.7 $36.06
3/31/20233,990,000 shares $144.56 million -10.5%7.7%9.6 $36.23
3/15/20234,460,000 shares $158.37 million -3.5%8.6%10.4 $35.51
2/28/20234,620,000 shares $173.67 million -4.7%8.9%11.5 $37.59
2/15/20234,850,000 shares $187.02 million -9.4%9.4%12.7 $38.56
1/31/20235,350,000 shares $219.40 million -3.3%10.3%13.2 $41.01
1/15/20235,530,000 shares $220.54 million +0.6%10.7%15 $39.88
12/30/20225,500,000 shares $196.19 million +11.8%10.6%14.3 $35.67
12/15/20224,920,000 shares $174.56 million -13.4%9.5%12.6 $35.48
11/30/20225,680,000 shares $208.57 million -0.5%11.0%14.6 $36.72
11/15/20225,710,000 shares $194.14 million -3.4%11.0%14.6 $34.00
10/31/20225,910,000 shares $202.54 million -1.8%11.5%14.6 $34.27
10/15/20226,020,000 shares $195.41 million -1.3%11.7%14.5 $32.46
9/30/20226,100,000 shares $206.49 million -0.7%11.9%14.6 $33.85
9/15/20226,140,000 shares $213.86 million +8.1%12.0%16.1 $34.83
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
8/31/20225,680,000 shares $194.43 million +3.8%11.1%15.5 $34.23
8/15/20225,470,000 shares $185.93 million -2.0%10.7%15.6 $33.99
7/31/20225,580,000 shares $177.17 million -0.9%11.0%14.5 $31.75
7/15/20225,630,000 shares $167.10 million +0.9%11.1%15.1 $29.68
6/30/20225,580,000 shares $161.37 million +1.3%11.0%13.5 $28.92
6/15/20225,510,000 shares $151.14 million -2.5%10.9%13 $27.43
5/31/20225,650,000 shares $157.47 million +6.6%11.0%13.5 $27.87
5/15/20225,300,000 shares $141.99 million +2.7%10.3%10.8 $26.79
4/30/20225,160,000 shares $143.96 million +1.8%10.1%10.9 $27.90
4/15/20225,070,000 shares $157.68 million +6.7%9.9%10.8 $31.10
3/31/20224,750,000 shares $153.52 million -2.1%9.3%10.6 $32.32
3/15/20224,850,000 shares $146.37 million -12.5%9.5%11.4 $30.18
2/28/20225,540,000 shares $177.00 million -19.4%10.8%11.9 $31.95
2/15/20226,870,000 shares $209.88 million -3.8%13.4%15.6 $30.55
1/31/20227,140,000 shares $220.27 million -3.9%13.9%16.9 $30.85
1/15/20227,430,000 shares $225.57 million +2.1%14.5%17.7 $30.36
12/31/20217,280,000 shares $212.28 million -5.1%14.2%16.9 $29.16
12/15/20217,670,000 shares $219.67 million +6.5%15.0%17.5 $28.64
11/30/20217,200,000 shares $215.78 million +0.3%14.1%17.9 $29.97
11/15/20217,180,000 shares $234.00 million -7.4%14.0%17.9 $32.59
10/29/20217,750,000 shares $231.34 million +1.8%15.1%19.6 $29.85
10/15/20217,610,000 shares $240.93 million -0.9%14.9%19.7 $31.66
9/30/20217,680,000 shares $204.83 million +1.9%15.0%19.4 $26.67
9/15/20217,540,000 shares $203.66 million +2.0%14.7%17.8 $27.01
8/31/20217,390,000 shares $203.45 million -1.5%14.4%16.6 $27.53
8/13/20217,500,000 shares $185.55 million No Change14.7%17.3 $24.74
7/30/20217,500,000 shares $197.48 million -6.7%14.7%17.1 $26.33
7/15/20218,040,000 shares $212.34 million -12.0%15.7%17.7 $26.41
6/30/20219,140,000 shares $281.42 million +8.4%17.9%20 $30.79
6/15/20218,430,000 shares $269.09 million -6.2%16.5%16.8 $31.92

SUPN Short Interest - Frequently Asked Questions

Short interest is the volume of Supernus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 5,418,515 shares of SUPN short. 10.24% of Supernus Pharmaceuticals' shares are currently sold short. Learn More on Supernus Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SUPN shares currently have a short interest ratio of 9.5. Learn More on Supernus Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.24% of Supernus Pharmaceuticals' floating shares are currently sold short.

Supernus Pharmaceuticals saw a increase in short interest during the month of May. As of May 29th, there was short interest totaling 5,418,515 shares, an increase of 14.5% from the previous total of 4,731,258 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

10.24% of Supernus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Supernus Pharmaceuticals: Corcept Therapeutics Incorporated (10.33%), Nektar Therapeutics (14.00%), Perrigo Company plc (10.94%), Pacira BioSciences, Inc. (17.91%), Omeros Corporation (25.81%), Assembly Biosciences, Inc. (11.16%), Cumberland Pharmaceuticals Inc. (4.09%), Eli Lilly and Company (1.04%), Johnson & Johnson (0.97%), AbbVie Inc. (1.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling SUPN is an investing strategy that aims to generate trading profit from Supernus Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Supernus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SUPN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SUPN, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SUPN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:SUPN) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel